Ireland Parkinsons Disease Market (2025-2031) | Competitive Landscape, Companies, Trends, Analysis, Forecast, Growth, Segmentation, Outlook, Industry, Share, Value, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 Ireland Parkinsons Disease Market - Industry Life Cycle

3.4 Ireland Parkinsons Disease Market - Porter's Five Forces

3.5 Ireland Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Ireland Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 Ireland Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Ireland Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 Ireland Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Parkinson's disease in Ireland

4.2.2 Technological advancements in Parkinson's disease treatment

4.2.3 Growing awareness and early diagnosis of the disease

4.2.4 Supportive government initiatives and funding for Parkinson's disease research and treatment

4.3 Market Restraints

4.3.1 High cost of Parkinson's disease medications and treatments

4.3.2 Limited access to specialized healthcare services for Parkinson's patients

4.3.3 Adverse side effects associated with certain Parkinson's disease medications

6.1 Ireland Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Ireland Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Ireland Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 Ireland Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 Ireland Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 Ireland Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 Ireland Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 Ireland Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 Ireland Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 Ireland Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 Ireland Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 Ireland Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Ireland Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Ireland Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 Ireland Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 Ireland Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 Ireland Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 Ireland Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Ireland Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 Ireland Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Ireland Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 Ireland Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 Ireland Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 Ireland Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 Ireland Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7.1 Ireland Parkinsons Disease Market Export to Major Countries

7.2 Ireland Parkinsons Disease Market Imports from Major Countries

8.1 Average age of diagnosis of Parkinson's disease in Ireland

8.2 Number of Parkinson's disease clinical trials conducted in Ireland

8.3 Percentage of Parkinson's disease patients receiving timely and appropriate treatment

8.4 Adoption rate of new technologies in Parkinson's disease management

8.5 Patient satisfaction with Parkinson's disease healthcare services

9.1 Ireland Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Ireland Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 Ireland Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Ireland Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 Ireland Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10.1 Ireland Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 Ireland Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters